Ted Monohon

Insider Reports History

Entity
Individual
Location
C/O Fantex, Inc., 330 Townsend St., Suite 234, San Francisco, CA
Signature
/s/ Ted Monohon
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ted Monohon:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Quince Therapeutics, Inc. Chief Accounting Officer & VP Common Stock 27.4K $25.8K $0.94 Mar 6, 2023 Direct
Quince Therapeutics, Inc. Chief Accounting Officer & VP Employee Stock Option (right to buy) 110K Feb 1, 2023 Direct

Insider Reports Filed by Ted Monohon

Symbol Company Period Transactions Value $ Form Type Date Filed Role
QNCX Quince Therapeutics, Inc. Mar 6, 2023 1 -$1.83K 4 Mar 6, 2023 Chief Accounting Officer & VP
QNCX Quince Therapeutics, Inc. Feb 1, 2023 1 $0 4 Feb 2, 2023 Chief Accounting Officer & VP
QNCX Quince Therapeutics, Inc. Dec 5, 2022 1 -$1.18K 4 Dec 7, 2022 Chief Accounting Officer & VP
QNCX Quince Therapeutics, Inc. Sep 6, 2022 1 -$2.49K 4 Sep 8, 2022 Chief Accounting Officer & VP
QNCX Cortexyme, Inc. Jun 29, 2022 1 $0 4 Jul 1, 2022 Chief Accounting Officer & VP
QNCX Cortexyme, Inc. Jun 6, 2022 1 -$4.77K 4 Jun 8, 2022 Chief Accounting Officer & VP
QNCX Cortexyme, Inc. Mar 3, 2022 1 $0 4 Mar 4, 2022 Chief Accounting Officer & VP
QNCX Cortexyme, Inc. Dec 14, 2021 1 $0 4 Jan 5, 2022 Chief Accounting Officer